tiprankstipranks

Jason Rhodes Insider Profile

4 Followers
Jason Rhodes, President, CFO and Treasurer at Epizyme, holds 847.32K shares in Dyne Therapeutics (Ticker: DYN), holds 8.28M shares in Generation Bio (Ticker: GBIO), holds 3.23M shares in Replimune Group (Ticker: REPL). Most recently, Jason Rhodes Sold ― shares of Dyne Therapeutics on Nov 18, 2024 for an estimated value of 25.88K.
tipranks
Jason Rhodes

Jason Rhodes
Epizyme (EPZM)
President, CFO and Treasurer

Ranked #12,230 out of 99,335 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+78.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$85M
56.91%
29.70%
13.39%
0.00%
A breakdown of Jason Rhodes's holdings

Insider Roles

Replimune Group
(REPL)
Director
Dyne Therapeutics
(DYN)
Director
Generation Bio
(GBIO)
Director
Disc Medicine
(IRON)
Director, Ten Percent Owner
Roles that Jason Rhodes holds in companies

Most Profitable Insider Trade

Stock:
Replimune Group
(REPL)
Rating:Informative Buy
Date:Nov 20, 2019 - Nov 20, 2020
Return:+276.70%
The most profitable trade made by Jason Rhodes

Jason Rhodes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EPZM
Epizyme
Sep 24, 2014
Informative Buy
22.44K
$202.86K
Replimune Group
Jan 28, 2021
Director
Uninformative Sell
256.45K
$48.21M
Generation Bio
Sep 29, 2021
Director
Uninformative Sell
2.06M
$11.34M
Dyne Therapeutics
Nov 18, 2024
Director
Informative Sell
25.88K
$25.16M
Disc Medicine
Director, Ten Percent Owner
List of latest transactions for each holding click on a transaction to see Jason Rhodes's performance on stock

Jason Rhodes insider profile FAQ

What is the percentage of profitable transactions made by Jason Rhodes?
The percentage of profitable transactions made by Jason Rhodes is 33%.
    What is the average return per transaction made by Jason Rhodes?
    The average return per transaction made by Jason Rhodes is 78.70%.
      What stocks does Jason Rhodes hold?
      Jason Rhodes holds: EPZM, REPL, GBIO, DYN, IRON stocks.
        What was Jason Rhodes’s latest transaction?
        Jason Rhodes latest transaction was an Informative Sell of $25.88K.
          What was Jason Rhodes's most profitable transaction?
          Jason Rhodes’s most profitable transaction was an Informative Buy of REPL stock on November 20, 2019. The return on the trade was 276.70%.
            What is Jason Rhodes's role in Epizyme?
            Jason Rhodes's role in Epizyme is President, CFO and Treasurer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.